云顶新耀 港股通 空最新增减持 (2026-06-04) 官网 ( 01952.hk) | -30.71 | 1.72 | 0% | 上市时间2020-10-09股价28.76港币涨跌幅-0.96%成交金额1.53亿港币换手率1.51%市值101.76亿港币H股市值101.76亿港币总股本3.54亿H股本3.54亿每手股数500上市至今年化投资收益率-15.28%港股通持仓占H股比例57.01% (57.73亿港币2026-06-03) 累计做空占H股比例5.60% (5.97亿港币2026-05-29) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 97.58 | 市净率 | 3.79 | 股息率 | 0.44% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 备注 (6): | 双击编辑备注 |
云顶新耀(01952) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 徐海音 | Independent Non Executive Director | 2023-01-19 | -- | |
| 2 | 羅永慶 | Executive Director | CEO | 2022-09-19 | -- |
| 3 | 康嵐 | Non Executive Director | 2020-12-22 | -- | |
| 4 | 蔣世東 | Independent Non Executive Director | 2020-09-25 | -- | |
| 5 | 李軼梵 | Independent Non Executive Director - A/F | 2020-09-25 | -- | |
| 6 | 譚擘 | Independent Non Executive Director | 2020-09-25 | 2023-01-19 | |
| 7 | 龔聿波 | Non Executive Director | 2020-06-03 | -- | |
| 8 | BLANCHARD Kerry Levan | Executive Director | 2020-02-25 | 2022-08-26 | |
| 9 | 何穎 | Executive Director | 2018-12-31 | -- | |
| 10 | 張曉帆 | Executive Director | 2017-11-23 | 2023-03-31 | |
| 11 | 傅唯 | Executive Director | Chairman | 2017-07-14 | -- |